Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03689049Not ApplicableActive Not Recruiting

SPIDER: A Research & QI Collaboration Supporting Practices in Improving Care for Complex Elderly Patients

Role: lead

NCT05197608Not ApplicableUnknown

At-risk and vulNerable Individuals To Infection With COVID-19 and ProActive inTervention With intEgrated Health and Social Care

Role: collaborator

NCT02987582Not ApplicableCompleted

A Feasibility Study of an Emotion-Focused Mindfulness Group

Role: lead

NCT01804881Not ApplicableCompleted

Effect of Managing Problematic Eating Behaviours With Dietary Management on Chronic Disease Self-management

Role: lead

All 4 trials loaded